Precision Medicine Collaboration and Licensing Deals 2018-2024


Precision Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2024

Publication date
May 2024
Number of pages
Product type
Research report
Available formats
PDF document
Report edition

Precision Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the precision medicine deals entered into by the worlds leading biopharma companies.

Fully revised and updated, the report provides details of precision medicine deals from 2018 to 2024.

The report provides a detailed understanding and analysis of how and why companies enter precision medicine deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. 

The report includes collaboration, development, research and licensing deals.

This report contains a comprehensive listing of 1319 precision medicine deals announced since 2018 including financial terms where available including links to online deal records of actual precision medicine partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of precision medicine dealmaking. 

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in precision medicine dealmaking since 2018.

Chapter 3 provides an overview of the leading precision medicine deals since 2018. Deals are listed by headline value.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in precision medicine dealmaking with a brief summary followed by a comprehensive listing of precision medicine deals, as well as contract documents available in the public domain.

Chapter 5 provides a comprehensive and detailed review of precision medicine deals signed and announced since Jan 2018, where a contract document is available in the public domain. 

Chapter 6 provides a comprehensive and detailed review of precision medicine partnering deals signed and announced since Jan 2018. The chapter is organized by specific precision medicine technology type in focus.

The report also includes numerous table and figures that illustrate the trends and activities in precision medicine deal making since 2018.

In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key benefits

Precision Medicine Collaboration and Licensing Deals provides the reader with the following key benefits:

•    Understand deal trends since 2018
•    Browse precision medicine collaboration and licensing deals
•    Benchmark analysis – identify market value of transactions
•    Financials terms - upfront, milestone, royalties
•    Directory of deals by company A-Z, deal type and therapy area
•    Leading deals by value
•    Most active dealmakers
•    Identify assets and deal terms for each transaction
•    Access contract documents - insights into deal structures
•    Due diligence - assess suitability of your proposed deal terms for partner companies
•    Save hundreds of hours of research time

Report scope

Precision Medicine Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of precision medicine trends and structure of deals entered into by leading biopharma companies worldwide.

Precision Medicine Collaboration and Licensing Deals includes:
•    Trends in precision medicine dealmaking in the biopharma industry
•    Directory of precision medicine deal records covering pharmaceutical and biotechnology
•    The leading precision medicine deals by value
•    Most active precision medicine licensing dealmakers

Precision Medicine Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

•    What are the precise rights granted or optioned?
•    What is actually granted by the agreement to the partner company?
•    What exclusivity is granted?
•    What is the payment structure for the deal?
•    How are sales and payments audited?
•    What is the deal term?
•    How are the key terms of the agreement defined?
•    How are IPRs handled and owned?
•    Who is responsible for commercialization?
•    Who is responsible for development, supply, and manufacture?
•    How is confidentiality and publication managed?
•    How are disputes to be resolved?
•    Under what conditions can the deal be terminated?
•    What happens when there is a change of ownership?
•    What sublicensing and subcontracting provisions have been agreed?
•    Which boilerplate clauses does the company insist upon?
•    Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
•    Which jurisdiction does the company insist upon for agreement law?

Precision Medicine Collaboration and Licensing Deals provides the reader with the following key benefits:

•    Understand deal trends since 2018
•    Browse precision medicine collaboration and licensing deals
•    Benchmark analysis – identify market value of transactions
•    Financials terms - upfront, milestone, royalties
•    Directory of deals by company A-Z, deal type and therapy area
•    Leading deals by value
•    Most active dealmakers
•    Identify assets and deal terms for each transaction
•    Access contract documents - insights into deal structures
•    Due diligence - assess suitability of your proposed deal terms for partner companies
•    Save hundreds of hours of research time

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in precision medicine dealmaking
2.1. Introduction
2.2. Precision medicine deals over the years
2.3. Most active precision medicine dealmakers
2.4. Precision medicine deals by deal type
2.5. Precision medicine deals by therapy area
2.6. Precision medicine deals by industry sector
2.7. Deal terms for precision medicine deals
2.7.1 Precision medicine deals headline values
2.7.2 Precision medicine deal upfront payments
2.7.3 Precision medicine deal milestone payments
2.7.4 Precision medicine royalty rates

Chapter 3 – Leading precision medicine deals
3.1. Introduction
3.2. Top precision medicine deals by value

Chapter 4 – Most active precision medicine dealmakers
4.1. Introduction
4.2. Most active precision medicine dealmakers
4.3. Most active precision medicine deals company profiles

Chapter 5 – Precision medicine contracts dealmaking directory
5.1. Introduction
5.2. Precision medicine contracts dealmaking directory

Chapter 6 – Precision medicine dealmaking by technology type

Deal directory

Deal directory – Precision medicine deals by company A-Z
Deal directory – Precision medicine deals by deal type
Deal directory – Precision medicine deals by therapy area

Deal type definitions

About Biopharma Research Ltd 
Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures

Figure 1: Precision medicine deals since 2018
Figure 2: Active precision medicine dealmaking activity – 2018 - 2024
Figure 3: Precision medicine deals by deal type since 2018
Figure 4: Precision medicine deals by therapy area since 2018
Figure 5: Precision medicine deals by industry sector since 2018
Figure 6: Precision medicine deals with a headline value
Figure 7: Precision medicine deals with an upfront value
Figure 8: Precision medicine deals with a milestone value
Figure 9: Precision medicine deals with a royalty rate value
Figure 10: Top precision medicine deals by value since 2018
Figure 11: Most active precision medicine dealmakers 2018 - 2024
Figure 12: Precision medicine deals by technology type since 2018

Pricing options

  • $3,995: single-user (encrypted file - one user/device)
  • $5,995: multi-user (encrypted file - up to 5 users/devices)
  • $9,995: company (unencrypted PDF)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.


Our guarantee


Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.


Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.


Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.


Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

1CellBiO, 2bPrecise, 2cureX, 2seventy bio, 4baseCare, 4bases, 4D Molecular Therapeutics, 4D Path, 10X Genomics, 22nd Century, 48Hour Discovery, A*STAR Bioinformatics Institute, A*STAR Singapore Immunology Network, A2 Biotherapeutics, Abbisko Therapeutics, Abbott Laboratories, Abbvie, Abcam, AbCellera Biologics, AbFero Pharmaceuticals, ABL Bio, ABX-CRO Advanced Pharmaceutical Services, Accelerated Cure Project for MS, Accelerate Technologies, AccessDx Laboratory, Access to Comprehensive Genomic Profiling Coalition, AccuGenomics, AccuStem Sciences, Acerta Pharma, Achilles Therapeutics, Aclipse Therapeutics, Acrivon Therapeutics, Acrobat Genomics, Active Motif, Adaptive Biotechnologies, ADC Therapeutics, Addario Lung Cancer Medical Institute, Adial Pharmaceuticals, Adiso Therapeutics, Adlai Nortye, Adrestia, AdventHealth, AESOP Technology, AgBiome, Age Labs, Agendia, Agilent Technologies, Agios Pharmaceuticals, Agribody Technologies, Agriplex Genomics, AHN Autoimmunity Institute, Aignostics, AIkido Pharma, AiLife Diagnostics, AimedBio, Akadeum Life Sciences, Akoya Biosciences, Alamar Biosciences, Alberta Health Services, Albert Einstein College of Medicine, Alcedis, Alchemab, Alector, Alexion Pharmaceuticals, All4Cure, Allarity Therapeutics, Allegheny General Hospital, Alligator Bioscience, Alloy Therapeutics, Allscripts, Allumiqs, Almac Diagnostics, Almac Group, Almaden Genomics, Alnylam Pharmaceuticals, Alphageneron Pharmaceuticals, Alto Neuroscience, Alyatec, Alzheimer's Drug Discovery Foundation, Amazon Web Services, Ambry Genetics, American Lung Association, American Skin Association, Amerimmune, Amgen, Amoy Diagnostics, AMRA Medical, Amydis, Analytical BioSciences, Analytics Engines, AnchorDx, Angers University, AnHeart Therapeutics, Anivive Lifesciences, Ankyra Therapeutics, Apollomics, Applied Biosystems, Applied Cells, Applied DNA Sciences, Aptorum Group, Arbor Biosciences, Arbor Biotechnologies, ArcherDX, ARCHIMEDlife, Arcis Biotechnology, Arcus Biosciences, Arena Pharmaceuticals, Ares Genetics, Ariadne Genomics, Ariana Pharma, AriBio, Ariel Precision Medicine, Arima Genomics, Arizona State University, AroCell, Artios Pharma, Arvinas, Asa Ren, Ashvattha Therapeutics, Aslan Pharma, Assistance Publique-Hôpitaux de Paris, Associazione Poic e Dintorni APS, Asthma UK, AstraZeneca, Asuragen, ATAI Life Sciences, Atara Biotherapeutics, Atlas Antibodies, AtlasXomics, AUM Biosciences, Aural Analytics, Australian Research Data Commons, Avance Biosciences, Avatamed, Avera Health, Avidity Biosciences, AXIM Biotechnologies, AyoxxA Biosystems, Babraham Institute, Banyan Biomarkers, Basepair, Basepaws, Battelle, Baxter International, Bayer, Bayer CropScience, Baylor College of Medicine, Baylor Genetics, Baylor Scott and White Research Institute, BC Cancer Agency, BC Platforms, Beacon Biosignals, Beckman Coulter, Becton Dickinson, Beijing Genomics Institute (BGI), Beijing Xisike Clinical Oncology Research Foundation, BenevolentAI, Benson Hill Biosystems, Berg, Berkeley Lights, Berry Genomics, Beth Israel Deaconess Medical Center, BGI Americas, Big Eye Diagnostics, BigOmics Analytics, Bill and Melinda Gates Foundation, Bio-Medical Science, Bio-Rad Laboratories, Bio-Techne, BioAge Labs, BioArctic AB, BioBright, Biocartis, Biocept, BioCheetah, Biocodices, Biodesix, Biofidelity, Biogen, Biogenar, Biogenysis, Biognosys, BioIntelliSense, BioLegend, BioLizard, BioLum Sciences, BioMap, BioMarin Pharmaceutical, Biomarker Collaborative, BioMarker Strategies, Biomedical Advanced Research and Development Authority, Biomedix, bioMerieux, BiomX, BioNano Genomics, Bionomics, BioNTech, BioReference Laboratories, Biosearch Technologies, BioSkryb, Biosplice, Biothera Pharmaceuticals, BioVectra, Bioz, Bird Foundation, BitBiome, Blackfynn, Blinktbi, Bliss Biopharmaceutical, Blockchain Global, Blu Biotech, Bluebee, Blue Cross Blue Shield Association, Blueprint Genetics, Blueprint Medicines, BlueRock Therapeutics, Boca Biolistics, Boehringer Ingelheim, BostonGene, Bpifrance, Brain Biomarker Solutions in Gothenburg, BRAINBox Solutions, BrainScope, Brain Trauma Foundation, Breath Diagnostics, Brenus Pharma, BriaCell Therapeutics, Bridge Biotherapeutics, Brigham and Women's Hospital, BrightPath Biotherapeutics, Bristol-Myers Squibb, Broad Clinical Labs, Broad Institute, Brown University, Buhler, Burning Rock, Busan Paik Hospital, C2i Genomics, C4X Discovery, California Institute for Biomedical Research, Calviri, Calyxt, Cambia Health Solutions, Cambridge Cancer Genomics, Cambridge Quantum Computing, CAMP4 Therapeutics, Canadian Council, Canary Speech, Cancer Research Horizons, Cancer Research UK, Canopy Biosciences, Cantabio Pharmaceuticals, Caraway Therapeutics, CareDx, Caribou Biosciences, Carina Biotech, Caring Cross, Caris Life Sciences, Carolina BioOncology Institute, Cartana, CarThera, CARTI Cancer Center, Case Western Reserve University, CASI Pharmaceuticals, Catholic University Leuven, CBD Solutions, Cedars-Sinai Medical Center, Celemics, Celgene, Cell and Gene Therapy Catapult, Cellaria Biosciences, CellChorus, Cellgen Diagnostics, Cellkey, Cell Mogrify, Cellworks, Celmatix, Celsius Therapeutics, Centene, Center for Aquaculture Technologies, Center for Biomarker Research in Medicine, Center for Forensic Science Research & Education, Centers for Disease Control and Prevention, Centogene, Centre for Clinical Cancer Research, Centre for Commercialization of Regenerative Medicine (CCRM), Centre for Research in Agricultural Genomics, Centre Leon Berard, Cerba Research, Certis, Cerveau Technologies, CGA 369, Chan Zuckerberg Initiative, Chao Center, Charcot-Marie-Tooth Association, Charite Universitatsmedizin Berlin, Chembio Diagnostics, Children's Hospital Boston, Children's Hospital of Philadelphia, Children's Medical Research Institute, Children’s Center for Cancer and Blood Diseases (CCCBD), Chinese Academy of Agricultural Science, Chinook Therapeutics, Christian Doppler Research Association, ChromaCode, Chroma Medicine, Chugai Pharmaceutical, CHU Sainte-Justine, Cicero Diagnostics, Cipherome, Circuit Clinical, Circular Genomics, City of Hope, CK Life Sciences, Cleveland Clinic, Clexio, Closed Loop Medicine, Clover Therapeutics, CMT Research Foundation, CND Life Sciences, Coastar Therapeutics, Codexis, Cofactor Genomics, Cogia Biotech, Cognition Therapeutics, CogState, Cohen Veterans Bioscience, Colorado Center for Personalized Medicine, Columbia University, Columbia University Medical Center, CombiGene, Companion Medical, Complete Genomics, ConcertAI, Concert Genetics, Concr, Congenica, Contextual Genomics, CoreBiome, Coriell Life Sciences, Cornell University, Corteva Agriscience, CosmosID, COTA, Covance, Covaris, Crohn's and Colitis Foundation of America, Crown Bioscience, Cryostem, CSI Laboratories, CStone Pharmaceuticals, Culmination Bio, CureMatch, CureScience, Curetis, CureVac, Curis, CvergenX, Cyclerion Therapeutics, Cyclica, CYduct Diagnostics, Cystic Fibrosis Foundation, CYTOVIA Therapeutics, Cytox, Daiichi Sankyo, Dana-Farber Cancer Institute, Danish Cancer Society Research Center, Danish Center for Strategic Research into Type 2 Diabetes, Dante Genomics, Dante Labs, DaRui Biotech, DarwinHealth, DataRobot, Data Tecnica International, Datavant, Day One Biopharmaceuticals, Deargen, Debiopharm, Decipher Biosciences, Decode Health, Deep Genomics, Deep Longevity, Defense Advanced Research Projects Agency, Definiens, DefiniGEN, Delfi Diagnostics, Denali Therapeutics, Dendreon, Denovo Biopharma, Department of Health - Abu Dhabi, Department of Veterans Affairs, Desktop Genetics, DestiNA Genomics, Devyser Diagnostics, DHR Health, Diaceutics, DiamiR, Diamyd Medical, Diatech Pharmacogenetics, Discovery Life Sciences, Divergence Neuro Technologies, Diversigen, DNAnexus, DNA Script, Dolomite Bio, DoMore Diagnostics, DrChrono, Duchenne UK, Duke-NUS Graduate Medical School Singapore, Duke University, Duke University Health System, DuPont, DuPont Pioneer, DxVx, e-NIOS, Eagle Genomics, Eccrine Systems, Edico Genome, Editas Medicine, Eisai, Element Biosciences, Elevation Oncology, Eli Lilly, Elo Life Systems, Elsevier, Elysium Health, EMBRAPA, EMD Serono, Emedgene, Emendo Biotherapeutics, EncrypGen, Endocanna Health, ENDRA Life Sciences, Enigma Biomedical, ENPICOM, Ensoma, Entheon Biomedical, Enzyvant Science, Epic, Epicore Biosystems, Epic Sciences, Epicypher, Epilepsy Society, Epivax, EpiVax Therapeutics, Epizyme, Erasmus University Medical Center, ERS Genomics, ErVimmune, Ethos Research & Development, Eucure Biopharma, Euformatics, Eureka Eurostars, Eurofins Scientific, European Commission, European Equity Partners, European Organization for Research and Treatment of Cancer, European Union, Evaxion Biotech, Evogen, Evonetix, Evotec, Evvy, Exactis Innovation, Exact Sciences, Exagen Diagnostics, Exosome Diagnostics, Exosome Sciences, ExScientia, F1 Oncology, Fabric Genomics, Factorial Biotechnologies, Factorial Diagnostics, Falco, FDNA, Ferring Pharmaceuticals, Fibrogen, Fight Colorectal Cancer, FinnGen, Firefly Neuroscience, First Genetics JCS, FivepHusion, Five Prime Therapeutics, Flagship Biosciences, Flare Therapeutics, Flatiron Health, Flow Pharma, Fluent BioSciences, Fluidigm, FMC, Food Allergy Research & Education, Food and Drug Administration (FDA), Forian, Fortis Life Sciences, Fortis Therapeutics, Foundation for Innovative New Diagnostics, Foundation for the National Institutes of Health (FNIH), Foundation Medicine, Fox Chase Cancer Center, FOXO Technologies, Fred Hutchinson Cancer Research Center, Freenome, Friends of Cancer Research, Front Range Biosciences, FSHD Global Research Foundation, Fujirebio Diagnostics, Fujitsu Laboratories, Fulgent Genetics, Fundacion Progreso y Salud, Fusion Antibodies, Fusion Genomics, Fusion Pharmaceuticals, FYR Diagnostics, G+FLAS Life Sciences, G1 Therapeutics, G42 Healthcare, Gabriella Miller Kids First Data Resource Center, Galmed Pharmaceuticals, Ganymede Bio, GATC Health, Gate Neurosciences, Gateway for Cancer Research, GC Genome, GEDmatch, Geisel School of Medicine at Dartmouth, Gemini Therapeutics, Gencove, GeneCentric Therapeutics, Genective, GeneDX, GeneMatters, Genentech, Geneoscopy, General Genomics, General Inception, Geneseeq, Genetica, Genetic Alliance, Genetic Technologies, Genetika+, Genetiks, Genetron Health, Genewiz, Geneyx, Genialis, Geninus, Genolution, Genome BC, Genome Canada, Genome Diagnostics, GenomeDx, Genome Insight, Genome Medical, Genomenon, Genome Prairie, Genomes2People, Genomic Biopharma, Genomics, Genomics England, Genomic Testing Cooperative, Genomic Vision, Genomind, Genomoncology, Genoox, GenoScreen, Genosity, Genprex, GenScript Biotech, Genspace, Genuity Science, GenXys, Genzeva, Georgetown University, German Cancer Research Center, German Federal Ministry of Education and Research, Gibson Oncology, GI Innovation, Gilead Sciences, Ginkgo BioWorks, Global Cancer Technology, Global Genomics Group, GlycoT Therapeutics, Glympse Bio, Gnosis Bioresearch, GNS Healthcare, Goldfinch Bio, Google, Government of Canada, Government of South Korea, Grail, Greenlight Biosciences, Gretel, Gritstone Bio, GSK, Guardant Health, Gusto Global, H3 Biomedicine, Hackensack Meridian Health, Hadassah Medical Center, Halia Therapeutics, HalioDx, Hamilton Company, Hamilton Robotics, Hannover Medical School, HaploX, Harvard Medical School, Harvard University, HAYA Therapeutics, Healix, Heartflow, Hebrew University of Jerusalem, Heligenics, Helix, Helomics, Henan Cancer Hospital, Hengenix Biotech, Hengrui Therapeutics, Henlius Biotech, Henry Ford Health System, Henry M. Jackson Foundation, HepaTx, Hepion Pharmaceuticals, Hereditary Neuropathy Foundation, HiberCell, Hitachi, Hitachi High-Technologies Corporation, Hoag Memorial Hospital Presbyterian, Horizon Discovery, Horizon Europe, Hospital for Sick Children, Hospital for Special Surgery, Hoth Therapeutics, HotSpot Therapeutics, HP, HTG Molecular Diagnostics, Hudson-Alpha Institute for Biotechnology, Human Cell Atlas, Hummingbird Bioscience, Hummingbird Diagnostics, Hurdle, I-mab, IBM, IBM Watson Health, Icahn School of Medicine at Mount Sinai, Icometrix, IDbyDNA, IDEAYA Biosciences, Igentify, Ikena Oncology, Illumina, ILUM Health Solutions, Image Analysis, ImaginAb, Imaware, IMBdx, Imec, Imeka, Immodulon Therapeutics, Immunai, Immunex, Immunovia, IMPACT Therapeutics, Imperial College London, Imugene, IncellDx, Incyte, Indiana University, Indica Labs, Indivumed, IndyGeneUS AI, Informed Data Systems, InfYnity Biomarkers, Inivata, INmune Bio, InnoBation, Innodem Neurosciences, Innoplexus, Innosuisse, Innovate UK, Innovative Genomics Initiative (IGI), Inotrem, Inovio Pharmaceuticals, Inserm, InsightRX, Insitro, InSphero, Institut Curie, Institute for Systems Biology, Institut Gustave Roussy, Integra, Integra Biosciences, Integrated DNA Technologies, Intel, Intellia Therapeutics, Intelligence Advanced Research Projects Activity (IARPA), Intelliseq, Intermountain Healthcare, Intermountain Precision Genomics, International Center for Genetic Engineering and Biotechnology, International Centers for Precision Oncology Foundation, International Myeloma Foundation, International Rice Research Institute, InterSystems, InterVenn, Intezyne, Invectys, Inventiva, inviCRO, Invitae, InVivoScribe, IO Biotech, Ionis Pharmaceuticals, iPrime Therapeutics, iProgen Biotech, IQVIA, iReceptor Plus, Isogenica, IsoPlexis, Israeli National Authority for Technological Innovation, iThera Medical, ITM Isotopen Technologien, IV BioHoldings, Ix Therapeutics, Jackson Laboratory, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, JASE Health, Jazz Pharmaceuticals, Jefferson Healthcare, Jeffrey Modell Foundation, Jenga Biosciences, Johns Hopkins University, Johnson & Johnson Innovation, JSR Life Sciences, Jubilant Therapeutics, Jumpcode Genomics, Juvenile Diabetes Research Foundation, Juventas Therapeutics, JW Biotechnology, K2bio, Kahn-Sagol-Maccabi, Kanazawa University, Kartos Therapeutics, Karyopharm Therapeutics, Kayagene, Keen Eye, Keio Gijuku University, KEW, Keygene, KeyWise, Khalpey AI Lab, Kineta, King Abdullah International Research Center, KingMed Diagnostics, Kings College London, Kiromic Biopharma, Kiyatec, Konica Minolta Precision Medicine, Koye Pharmaceuticals, KPMG, Kronos Bio, Kura Oncology, Kymera Therapeutics, Kytopen, Kyverna Therapeutics, L'Oreal, Laboratorio Curie, Laboratory Corporation of America, La Jolla Institute for Allergy & Immunology, Lantern Pharma, Lantheus Holding, Latvian Institute of Organic Synthesis, Lawson Health Research Institute, Leap Therapeutics, Lee Moffitt Cancer Center, Lehigh Valley Health Network, Leibniz-Institut fur Molekulare Pharmakologie, Leica Biosystems, Lenovo, LEO Pharma, Lesaffre, Les Laboratoires Servier, Lexent Bio, LEXEO Therapeutics, Lexogen, LGC, LifeLabs Medical Laboratory Services, LifeMap Sciences, LifeOmic, Life Raft Group, Li Ka Shing Foundation, Linus Biotechnology, Lipidomics Consulting, Liquid Biosciences, Livongo Health, LMU University Hospital Munich, Locus Biosciences, LogicBio Therapeutics, Longenesis, Lonza, Loxo Oncology, Lucid Diagnostics, Lunaphore, Lung Cancer Research Foundation, Lunit, Lupus Research Alliance, Maccabi Healthcare Services, Macrogen, Mainz Biomed, Mannin Research, MapKure, Massachusetts General Hospital, Massachusetts Institute of Technology, Mass General Brigham, Massive Bio, Mater Research, Maxim Integrated, Maxim Ventures, Mayo Clinic, MBio Diagnostics, MC10, McKesson, McMaster University, MD Anderson Cancer Center, MD Biosciences, Medaffcon, Medgenics, MedGenome, MEDIAN Technologies, Medical College of Georgia, Medical College of Wisconsin, Medical Research Council, Medical University of Graz, Medical University of Vienna, Medicinal Genomics, Medicines Discovery Catapult, MEDiC Life Sciences, Medicover, Medidata Solutions, MediSapiens, Medivizor, MedStar Health Research Institute (MHRI), Medx, Meharry Medical College, Meiogenix, Mekonos, Memorial Sloan Kettering Cancer Center, Menarini Silicon Biosystems, Merck and Co, Merck KGaA, Merus, Mesh Bio, Metabolon, Metis Therapeutics, MGI Pharma, MGI Tech, Michael J Fox Foundation, Michelson Center, Microba Life Sciences, Microbiotica, MicroGenDX, MicroMGx, Micronoma, Microsoft, Mie University, MindImmune Therapeutics, Mind Medicine, Mindstrong Health, Mirada Medical, Mirati Therapeutics, miRecule, Mirnax Biosens, Miroculus, Mirus Bio, MiRXES, Mission Bio, Mission Cure, Mitra Biotech, Mitsubishi Tanabe Pharma, MOBILion Systems, Moderna, Molbio Diagnostics, Molecular Health, Moleculera Labs, Mologen, Monsanto, Montreal Heart Institute, MorphoSys, Moss Genomics, MP Group, mProbe Laboratories, MRM Proteomics, Multimmune, MultiOmic Health, Multiple Myeloma Research Foundation, Multiplex Genomics, Multiply Labs, Muscular Dystrophy Association, MyBiotics Pharma, My Care Express Merrillville, MYND Life Sciences, myNEO, My Personal Therapeutics, Myriad Genetics, Myrtelle, MyVytalics, n-Lorem Foundation, NABsys, Nalagenetics, Namocell, Nankai Hospital, NanoCellect Biomedica, NanoMab Technology, Nanostics Precision Health, NanoString Technologies, NanoView Biosciences, Nashville Biosciences, NATA, Natera, National Cancer Center, National Cancer Center of Japan, National Cancer Centre Singapore, National Cancer Institute, National Comprehensive Cancer Network (NCCN), National Health Service, National Human Genome Research Institute, National Institute for Health Research (NIHR), National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal Diseases, National Institute of Child Health and Human Development, National Institute of General Medical Sciences, National Institute on Aging, National Institutes of Health, National Science Foundation, Naval Medical Research Center, Navican, Navidea Biopharmaceuticals, Navigate BioPharma Services, Navigo Proteins, Navinci Diagnostics, Nebraska Medicine, Nebula Genomics, NEC, Negen, Nektar Therapeutics, Neo7Bioscience, Neochromosome, NeoDynamics, Neogap Therapeutics, Neogen, Neogenomics, Neon Therapeutics, Neoteryx, Nepean Blue Mountains Local Health District’s Nepean Hospital, NervGen Pharma, Netherlands Cancer Institute, NetraMark, Neumora Therapeutics, NeuraLight, NeurExo Sciences, NeuroGenesis, NeuroLex Laboratories, NeuroMetrix, Neuron23, NeuroSense Therapeutics, NeuroTrauma, New England Biolabs, New Horizon Health, Newomics, NewStem, New York Blood Center, New York Genome Center (NYGC), New York State Department of Health, New York University School of Medicine, Next Generation Manufacturing Canada, NGeneBio, Nico, Nilogen Oncosystems, NIMML Institute, NImmune Biopharma, Nippon Kayaku, Nitto Avecia, NMI Natural and Medical Sciences Institute, Nonacus, Normunity, Northern RNA, North Med, Northwell Health, Northwestern University, Notable Labs, Novartis, NovellusDx, Novigenix, Novogene, Novo Nordisk, Nrgene, Nucleai, Nucleix, Numares, NuMedii, NuProbe, Nurosene, Nvidia, NYU Grossman School of Medicine for Preclinical and Clinical Research, Ocean Genomics, Octant, Odimma Therapeutics, Offspring Biosciences, Ohio State University, Oklahoma Medical Research Foundation, Olaris, Olink Bioscience, Olink Proteomics, OMAPiX, Omico, OmniaBio, Omniome, Oncoceutics, OncoCyte, Oncodesign, OncoDNA, OncoGenesis, Oncoheroes Biosciences, OncoHost, OncoImmunity, Oncologie, Oncology Venture, Oncompass Medicine, Onconova Therapeutics, Oncora Medical, Oncoshot, OncXerna Therapeutics, One Biosciences, One Codex, OneOncology, OneThree Biotech, ONK Therapeutics, Ono Pharmaceutical, Onramp Bioinformatics, Ontario Institute for Cancer Research, OpenBench, Open Medicine Institute, Opentrons Labworks, OpGen, Optellum, Optina Diagnostics, OracleBio, Orchid Cellmark, Ordaos Bio, Oregon Health Sciences University, OrigiMed, Origin Agritech, Oryzon, OSE Immunotherapeutics, Oslo University Hospital, Oswaldo Cruz Foundation (Fiocruz), Ovation, Owkin, Owlstone Medical, Oxford Biodynamics, Oxford Nanopore Technologies, Ozette Technologies, Pacific Biosciences, Paige, Pairwise Plants, Pancreatic Cancer Action Network, Pancreatic Cancer Collective, Pangea Biomed, Paragon Genomics, Parent Project Muscular Dystrophy, Parexel, Parse Biosciences, Partek, Partner Therapeutics, PathAI, Path BioAnalytics, PathGroup, Patia, Paul Scherrer Institute, PAVmed, PEAR Therapeutics, Pennsylvania State University, Pepscan, PerkinElmer, Persephone Biosciences, Personal Genome Diagnostics, Personalis, Perthera, PetaGene, Pfizer, Pharmanovia, Pharnext, Pharus Diagnostics, Phase Genomics, Phenomix, Physiomics, PhysIQ, Pierian, PierianDx, Pierre Fabre, Pillar Biosciences, Pioneer Hi-Bred, Pionyr Immunotherapeutics, PlaqueTec, PlumCare, Pluristem Therapeutics, Pluristyx, Plus Therapeutics, Poietis, PPD, PreciseDx, Precision BioSciences, Precision Diabetes, Precision for Medicine, Precision Health Informatics, PrecisionLife, Precision NanoSystems, Precision Therapeutics, Predicine, PredictImmune, Predictive Oncology, Prelude Therapeutics, Premier Inc, PreMIT, Prenetics, Prenosis, Prepaire Labs, Prescient Medical, Prevacus, Princess Margaret Hospital, Progentec Diagnostics, Progknowse, PrognomIQ, Prognos, Prolytix, Promega, Prometheus Biosciences, Prometheus Laboratories, ProPath, Prophase Labs, Proscia, Prostate Cancer Clinical Trials Consortium, Protagen, Protean BioDiagnostics, Proteic Bioscience, ProteoMediX, Proteona, Proteus Genomics, Protxx, Provista Diagnostics, Pryzm Health, Psomagen, Pulmonary Fibrosis Foundation (PFF), Puma Biotechnology, Q-State Biosciences, Q2 Solutions, Qatar Foundation, Q BioMed, QED Therapeutics, Qiagen, Quadrant Biosciences, Quanterix, Quantinm, QuantumDx, Quantum Leap Health Care Collaborative, Queen Mary University of London, Quest Diagnostics, Quotient, QurAlis, R-Pharm, rAAVen Therapeutics, Race Oncology, Radius Health, Rady Children's Institute for Genomic Medicine, RareCyte, RayBiotech, RCK, Readout Health, Realm IDx, Recombia Biosciences, Redx Pharma, RefleXion Medical, Regeneron Genetics Center, Regeneron Pharmaceuticals, Regulus Therapeutics, Related Sciences, Relay Therapeutics, Renato Dulbecco Foundation, Renji Hospital, Rensselaer Polytechnic Institute, Repare Therapeutics, Repertoire Genesis, Replicate Bioscience, Research Council of Norway, Resilient Biotics, Resolution Bioscience, Resolve Biosciences, Reveal Biosciences, Reveal Genomics, Revitalist Lifestyle and Wellness, Revive Therapeutics, Revolution Medicines, Revvity, Rheos Medicines, Rhythm Pharmaceuticals, Rice University, Ricoh, RIKEN Center for Integrative Medical Sciences, RIKEN Research Institute, Ripe Technology, Roche, Roche Diagnostics, Roche Molecular Systems, Rockefeller University, Rockley Photonics, Roswell Biotechnologies, Royal College of Surgeons (Ireland), Royal Philips Electronics, RTI International, Rush University Medical Center, Rutgers Cancer Institute of New Jersey, Rutgers University, RxGenomix, Ryailti, S2 Genomics, Saga University, Sana Biotechnology, Sanford Health, Sangamo Therapeutics, Sanofi, Sano Genetics, Saol Therapeutics, Saphetor, Sarah Cannon Research Institute, Sarepta Therapeutics, Scailyte, Scale Biosciences, Scandion Oncology, Scarab Genomics, Schrodinger, Scipher Medicine, Scorpion Therapeutics, Scripps Translational Science Institute, Secarna Pharmaceuticals, Second Genome, SeLux Diagnostics, Sema4, Seneca Therapeutics, Sengenics, SEngine Precision Medicine, Sensyne Health, Sentieon, Sentinel Diagnostics, SenzaGen, Seoul National University, Seqster, Sequentify, SeQure Dx, SeqWell, Seracare Life Sciences, Serokell, Serosep, Serotiny, Seven Bridges Genomics, Shanghai ChemPartner, Sheffield Institute for Translational Neuroscience, Shenzhen Chipscreen Biosciences, Shepherd Therapeutics, Shimadzu, Shire Human Genetic Therapies, Shivom, Shuttle Pharmaceuticals, Shuwen Biotech, Siemens Healthineers, SimBioSys, Simsen Diagnostics, Singapore Eye Research Institute (SERI), Singleron Biotechnologies, Singular Genomics Systems, Sirona Dx, SkylineDX, Skysong Innovations, Sohm, SomaLogic, Sonde Health, Sonrai Analytics, Sookmyung Women's University, SOPHiA Genetics, Soricimed Biopharma, Sorrento Therapeutics, Sosei Heptares, Spanish National Cancer Research Centre, Spark Biomedical, Spatial Genomics, Spectrum Pharmaceuticals, Spectrum Solutions, SpeeDx, Spesana, SPT Labtech, SQI Diagnostics, SquareOne Wellness, SRI International, SRL, St. Jude Children's Research Hospital, Stalicla, Stallargenes, Stallergenes Greer, Standard BioTools, Stanford University, Stanford University School of Medicine, Stella Diagnostics, Stem Genomics, Stem Pharm, Step Pharma, St Luke's University Health Network of Bethlehem, Stockholm University, Strata Oncology, STRATIFYER Molecular Pathology, Streck Laboratories, Structural Genomics Consortium, Sumitovant Biopharma, Sunnybrook Research Institute, Sun Pharma Advanced Research Company, SunTerra Biotechnology, SUNY Upstate Medical University, Susan G. Komen for the Cure, Sutro Biopharma, Swift Biosciences, Swiss Institute of Bioinformatics (SIB), Syapse, Syncromune, SynGAP Research Fund, Syngenta, Synthego, Syros Pharmaceuticals, Sysmex, Sysmex Inostics, T-Cure Bioscience, Tabula Rasa HealthCare, Taiwan Precision Medicine Initiative, Takara Bio, Takeda Pharmaceutical, Takeda Ventures, Tampa General Hospital Cancer Institute, Tampere University Hospital, Tango Therapeutics, Tasly Pharmaceuticals, Tavros Therapeutics, Taysha Gene Therapies, Tecan, Telix Pharmaceuticals, Tempus, Tennessee Oncology, TeraRecon, Terran Biosciences, Tesis Biosciences, Tessera Therapeutics, TGen Drug Development, The Cure Parkinson's Trust, The New York Stem Cell Foundation, The Parker Institute For Cancer Immunotherapy, Theralink Technologies, Theraly Fibrosis, TheraPanacea, Thermo Fisher Scientific, The Silverstein Foundation for Parkinson's, Thomas Jefferson University, Todos Medical, Tokyo Medical and Dental University, TONIX Pharmaceuticals, Toronto Innovation Acceleration Partners, Tor Vergata University Hospital, Total Brain, Tow Foundation, TP Therapeutics, Traaser, Trajan Scientific and Medical, Trakcel, Transcenta, Transgene, Translational Drug Development, Translational Genomics Research Institute, Translational Software, Transnetyx, Transomic Technologies, Travera, Trialbee, TrovaGene, TruGenomix, TScan Therapeutics, TumorGenesis, Turnstone Biologics, Twinstrand Therapeutics, Twist Bioscience, Tymora Analytical Operations, uBiome, UCB, Ultima Genomics, Ultivue, Umoja Biopharma, Unilabs, Univeristy of Durham, University College London, University Health Network, University Hospital Heidelberg, University Hospitals Case Medical Center, University of Adelaide, University of Alabama at Birmingham, University of Alberta, University of Arizona, University of Arkansas, University of Bern, University of Bonn, University of British Columbia, University of Buffalo, University of California, San Diego, University of California Berkeley, University of California Irvine, University of California Los Angeles, University of California San Francisco, University of California Santa Cruz, University of Chicago, University of Cincinnati, University of Colorado, University of Colorado Denver, University of Florida, University of Greifswald, University of Heidelberg, University of Hong Kong, University of Houston, University of Illinois, University of Illinois Urbana-Champaign, University of Lausanne, University of Leeds, University of Ljubljana, University of Manchester, University of Maryland, University of Maryland Baltimore, University of Massachusetts, University of Miami, University of Michigan, University of Minnesota, University of Nebraska, University of Newcastle, University of New South Wales, University of North Carolina, University of Ottowa, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Rochester, University of Rostock, University of Sheffield, University of Sydney, University of Texas, University of Texas Health Science Center at Houston, University of Tokyo, University of Toronto, University of Tubingen, University of Verona, University of Washington, University of Wisconsin, University of Wisconsin Carbone Cancer Center (UWCCC), University of Wollongong, US Oncology, Vaccinex, Valence Discovery, Vall d’Hebron Research Institute, Valo Health, Vanderbilt University, Varian Medical Systems, Vector Laboratories, Veracyte, Veravas, Veraxa Biotech, Verge Genomics, Verily, VeriSIM Life, Veritas, Veritas Genetics, Verogen, Versea Ophthalmics, Vertex Pharmaceuticals, VGI Health Technology, VIB, Vibrent Health, Victoria University, VieCure, ViewMind, Viewpoint Molecular Targeting, ViewRay, Viome, Vir Biotechnology, Virginia Commonwealth University, Visiopharm, Vitaccess, Vivante Health, Vividion Therapeutics, Vizgen, Vocalis Health, Volta Labs, Voltron Therapeutics, Voronoi, Vyant Bio, Washington University in St Louis, Watchmaker Genomics, WAVE Life Sciences, Wearifi, Weihai Weigao Medical Devices, Weill Cornell Medical College, Wellcome Trust Sanger Institute, Wellmarker Bio, Western Digital, WIN Consortium, WinterLight Labs, WuXi NextCODE Genomics, Wuxi STA, Xcell Biosciences, xCures, Xencor, Xpress Technologies, XtalPi, Yale Cancer Center, Yale School of Medicine, Yale University, Yeda Research and Development Company, Yield10 Bioscience, Yissum Research Development, Ymir Genomics, ZAI Laboratory, ZERO Childhood Cancer, ZS Pharma, Zymergen, Zymo Research

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.